Is There an Authoritarian Advantage in Pandemic Response? A Comparative Case Study of China's Responses to SARS-CoV-1 (2003) and SARS-CoV-2 (2019)

JONATHAN SCHWARTZ

《Issues & Studies》 58卷2期 (2022/06) Pp. 1-27

https://doi.org/10.1142/S1013251122500011

摘要

Effective pandemic response has become an increasingly important focus for research in the face of the COVID-19 pandemic. While there are a number of variables that may be considered as influencing effective response, this paper focuses on the potential impact of an ＂authoritarian advantage＂ in achieving an effective response in the period prior to pharmaceutical interventions being available with China as a case study. In essence, this paper explores whether China enjoys an authoritarian advantage, and if so, how it functions. This study compares China's SARS-CoV-1 (2003) response with its SARS-CoV-2 (2019) response by exploring the impact of the authoritarian advantage on the state's ability to effectively engage three key explanatory variables - centralized decision-making powers, public support and media engagement.

關鍵字

China ； authoritarian advantage ； pandemic response ； effectiveness

參考文獻

Mehta, M., Sarvaiya, H., & Chandani, A. (2020). Community engagement through responsible leadership in managing pandemic: Insight from India using netnography. International Journal of Sociology and Social Policy. https://doi.org/10.1108/IJSSP-06-2020-0214

Andersen, R. (2020, September). The Panopticon is already here. The Atlantic.

Ang, Y. Y. (2020). When COVID-19 meets centralized, personalized power. Nature Human Behaviour, 4, 445–447.

BJC Healthcare. (2021, January 14). Timeline of COVID-19 vaccine development.

Backlash to Wuhan Diary author Fang Fang continues. (2020, May 1). China Digital Times.